U.S. markets closed
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • Dow 30

    29,590.41
    -486.27 (-1.62%)
     
  • Nasdaq

    10,867.93
    -198.88 (-1.80%)
     
  • Russell 2000

    1,679.59
    -42.72 (-2.48%)
     
  • Crude Oil

    79.43
    -4.06 (-4.86%)
     
  • Gold

    1,651.70
    -29.40 (-1.75%)
     
  • Silver

    18.83
    -0.78 (-3.99%)
     
  • EUR/USD

    0.9693
    -0.0145 (-1.47%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • GBP/USD

    1.0857
    -0.0398 (-3.54%)
     
  • USD/JPY

    143.3300
    +0.9950 (+0.70%)
     
  • BTC-USD

    19,077.19
    +20.12 (+0.11%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    27,153.83
    -159.30 (-0.58%)
     

Zevia Shares Soar On Better-Than-Expected Q2 Top-Line Performance

·1 min read
  • Zevia PBC (NYSE: ZVIA) reported second-quarter FY22 sales growth of 33% year-on-year to $45.54 million, beating the consensus of $42.17 million.

  • Unit volume climbed 30% Y/Y to 3.9 million equivalized cases.

  • Gross profit grew 7% to $17.4 million, while the margin contracted 920 basis points to 38.1%, reflecting the impact of broad-based inflationary pressures.

  • Loss from operations for the quarter widened sharply to $(14.7) million.

  • The company held $49.6 million in cash and equivalents as of June 30, 2022.

  • EPS loss for the quarter was $(0.28). Adjusted EBITDA loss for the quarter widened to $(6.4) million.

  • "Growth was balanced across channels as we continued to expand our distribution with new and existing customers," said CEO Amy Taylor.

  • Outlook: Zevia maintained its FY22 sales forecast of $177 million - $182 million, versus the consensus of $178.49 million.

  • The company expects Q3 sales of $46 million - $48 million, below the estimate of $52.15 million.

  • Price Action: ZVIA shares are trading higher by 16.22% at $3.94 on the last check Thursday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.